The Elitek or Fasturtec market has seen notable expansion in recent years, driven by rising cases of tumor lysis syndrome (TLS) and the increasing prevalence of cancer-related conditions.

They have been described in association with infection, autoimmune disorders, cancer, and allograft rejection. In their mature stage, TLS function as ectopic germinal centers, favoring the local ...

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...

Tumor Lysis Syndrome: Cases of Tumor Lysis Syndrome (TLS), including fatal cases, have been reported in patients with CML, GIST, ALL, and eosinophilic leukemia receiving imatinib. The patients at ...

In addition to REGENCY, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...

Aging is a prominent risk factor for many neurodegenerative disorders, such as Alzheimer’s disease (AD). Alzheimer’s disease is characterized by progressive cognitive decline, memory loss, and ...

The accepting host (AH) accepts the communication from the initiating host (IH) after the SDP controller authenticates and authorizes the connection. The SDP controller instructs the accepting SDP ...

The analysts also addressed concerns about the current stock price, which they believe may be undervaluing Denali’s DNL126 program for Sanfilippo syndrome, due to the anticipated earlier launch of a ...